Trial site
Guys and St Thomas NHS Foundation Trust
- 14running trials
- 13closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Myeloproliferative neoplasms3 trials
- Ovarian cancer3 trials
- Psoriasis3 trials
- Triple-negative breast cancer3 trials
- Atrial fibrillation2 trials
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Head and neck cancer2 trials
- Heart failure2 trials
- Liver and biliary tract cancer2 trials
- and 15 more
- Phase
- Phase 38 trials
- Phase 16 trials
- Phase 24 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Completed9 trials
- Recruiting5 trials
- Terminated4 trials
- Lead sponsor
- Incyte Corporation6 trials
- Janssen Research & Development, LLC5 trials
- Guy's and St Thomas' NHS Foundation Trust2 trials
- Janssen-Cilag Ltd.2 trials
- Boston Scientific Corporation1 trial
- and 11 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
Active, not recruiting
Recruiting
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure2 recruiting
- Atrial fibrillation1 recruiting
- Childhood cancers1 recruiting
- Chronic rhinosinusitis with nasal polyps1 recruiting
- Lung cancer1 recruiting
Closed trials
Terminated
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Recruiting
Completed
Completed
Terminated
Completed
Terminated
Completed
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
Completed
Completed
Completed
Terminated
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
Completed
PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer
Site data: ClinicalTrials.govUpdated 15 Nov 2026